Boehringer Ingelheim Pharma GmbH & Co. KG

Form 483FOIA Uncovered

Ingelheim am Rhein, -FEI 3002806556Issued May 04, 2018

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3002806556.

ObservationsNot available

Issue DateMay 04, 2018

StatusNo Warning Letter

Related Inspections9

Establishment Details

Firm: Boehringer Ingelheim Pharma GmbH & Co. KG
Location: Ingelheim am Rhein, -
FEI Number: 3002806556
Product Type: Drugs
Issue Date: May 04, 2018
Country: United States

Inspection History, 2009 to 2025

NAI3

VAI5

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Boehringer Ingelheim Pharma GmbH & Co. KG FDA Form 483, Ingelheim am Rhein, May 4, 2018